Immutep Total Liab from 2010 to 2025

IMMP Stock  USD 1.88  0.02  1.05%   
Immutep Total Liabilities yearly trend continues to be relatively stable with very little volatility. Total Liabilities is likely to drop to about 7.8 M. Total Liabilities is the total amount of all liabilities that Immutep Ltd ADR has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2011-06-30
Previous Quarter
12.1 M
Current Value
9.9 M
Quarterly Volatility
4.3 M
 
Yuan Drop
 
Covid
Check Immutep financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immutep's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 26.2 K or Selling General Administrative of 9.3 M, as well as many indicators such as Price To Sales Ratio of 80.26, Dividend Yield of 0.0 or PTB Ratio of 2.06. Immutep financial statements analysis is a perfect complement when working with Immutep Valuation or Volatility modules.
  
Check out the analysis of Immutep Correlation against competitors.

Latest Immutep's Total Liab Growth Pattern

Below is the plot of the Total Liab of Immutep Ltd ADR over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Immutep's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immutep's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Immutep Total Liab Regression Statistics

Arithmetic Mean8,592,635
Geometric Mean6,469,993
Coefficient Of Variation52.34
Mean Deviation3,555,292
Median8,431,490
Standard Deviation4,497,564
Sample Variance20.2T
Range16M
R-Value0.69
Mean Square Error11.4T
R-Squared0.47
Significance0
Slope649,723
Total Sum of Squares303.4T

Immutep Total Liab History

20257.8 M
202413.9 M
202312.1 M
202211 M
20218.1 M
20208.8 M
201913.3 M

About Immutep Financial Statements

Immutep shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although Immutep investors may analyze each financial statement separately, they are all interrelated. The changes in Immutep's assets and liabilities, for example, are also reflected in the revenues and expenses on on Immutep's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities13.9 M7.8 M

Additional Tools for Immutep Stock Analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.